Nadia Litterman

last updated 3/5/2018

Nadia Litterman

Collaborations Director at Collaborative Drug Discovery Inc

Location:
1633 Bayshore Hwy Suite 342, Burlingame, California, United States
HQ Phone:
(650) 204-3084

General Information

Experience

Senior Project Manager - 23andMe Inc

Education

Ph.D.

Affiliations

Scientific Advisory Board Member - Hereditary Neuropathy Foundation Inc

Member, Collaborations Director, Collaborative Drug Discovery - Harvard University

Graduate Research Fellow - National Science Foundation

Recent News  

Scientific Advisory Board

Nadia Litterman, Ph.D
Nadia Litterman, Ph.D PhD is Collaborations Director at Collaborative Drug Discovery (CDD) Nadia Litterman, PhD is Collaborations Director at Collaborative Drug Discovery (CDD), where she aims to identify and develop collaborations for drug discovery using CDD's innovative informatics technologies. She has a long standing interesting in finding therapeutics for neuronal disorders and rare diseases, with more than 10 years of broad research experience in the areas of chemistry, cell biology, and neuroscience.

Read More
Leadership Team | CDD | Drug Informatics

Nadia Litterman, Ph.D.
Scientist and Project Manager at 23andMe - Dr. Nadia Litterman is currently a scientist and project manager at 23andMe, a leading personal genetics company based in California. Before joining 23andMe, Dr. Litterman served as Collaborations Director at CDD, where she focused her efforts on new technology and computational tools for developing therapeutics. Dr. Litterman earned a PhD at Harvard University, where she conducted postdoctoral research in the screening laboratory of Dr. Lee Rubin, at the Department of Stem Cell and Regenerative Biology. Dr. Litterman's research identified small molecules to reverse the cellular phenotypes of the rare disease Spinal Muscular Atrophy. She also studied how systemic factors lead to the rejuvenation of the aging brain. As a National Science Foundation Graduate Research Fellow, Dr. Litterman examined ubiquitin ligase regulation of neuronal morphology in the laboratory of Dr. Azad Bonni at Harvard Medical School.

Read More
Leadership Team | CDD | Drug Informatics

Nadia Litterman, Ph.D.
Scientist and Project Manager at 23andMe - Dr. Nadia Litterman is currently a scientist and project manager at 23andMe, a leading personal genetics company based in California. Before joining 23andMe, Dr. Litterman served as Collaborations Director at CDD, where she focused her efforts on new technology and computational tools for developing therapeutics. Dr. Litterman earned a PhD at Harvard University, where she conducted postdoctoral research in the screening laboratory of Dr. Lee Rubin, at the Department of Stem Cell and Regenerative Biology. Dr. Litterman's research identified small molecules to reverse the cellular phenotypes of the rare disease Spinal Muscular Atrophy. She also studied how systemic factors lead to the rejuvenation of the aging brain. As a National Science Foundation Graduate Research Fellow, Dr. Litterman examined ubiquitin ligase regulation of neuronal morphology in the laboratory of Dr. Azad Bonni at Harvard Medical School.

Read More

Browse ZoomInfo’s Directories